Genetic variation in cyclooxygenase 1: Effects on response to aspirin
The DOI matches its Crossref record.
Abstract
Background: A critical clinical application of the Human Genome Project is to identify functional variation in genes related to disease or responses to xenobiotics. This study moved toward that goal by combining polymorphism detection with functional assays for the therapeutic target gene cyclooxygenase 1 (COX‐1). Cyclooxygenase 1 (prostaglandin endoperoxide G/H synthase [PTGS1]) catalyzes the metabolism of arachidonic acid to prostaglandin H 2, which is subsequently metabolized to thromboxane A 2. Methods: Thirty‐eight healthy participants were enrolled in this study to correlate functional and genetic variation of cyclooxygenase 1. Arachidonic acid, with and without aspirin (acetylsalicylic acid) and ethanol pretreatment, was used to stimulate the formation of prostaglandin H 2, measured as prostaglandin F 2α (PGF 2α), in human platelets. The cyclooxygenase 1 complementary deoxyribonucleic acid coding sequence and genomic deoxyribonucleic acid upstream from the cyclooxygenase 1 transcription start site (2.9 kilobases) were sequenced in 38 individuals, with 9 single‐nucleotide polymorphisms identified. Results: Two single‐nucleotide polymorphisms, A‐842G and C50T, were in complete linkage disequilibrium. Participants who were heterozygous for the A‐842G/C50T haplotype showed significantly (P = .01) greater inhibition of prostaglandin H 2 formation by acetylsalicylic acid (30 μmol/L) compared with common allele homozygotes. Conclusions: The discovery of a functional single‐nucleotide polymorphism in the cyclooxygenase 1 locus may ultimately improve the safe and effective use of acetylsalicylic acid by better tailoring of dosage with an individual's genetic variation. Clinical Pharmacology & Therapeutics (2003) 73, 122–130; doi: 10.1067/mcp.2003.1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
CUISSET, T., FRERE, C., QUILICI, J., BARBOU, F., MORANGE, P. E., HOVASSE, T., BONNET, J., & ALESSI, M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01751.x · Cited by 369
Aspirin resistance: definition, mechanisms and clinical read-outs
Patrono, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00284.x · Cited by 299
Metadata
- Authors
- Halushka, M. K., Walker, L. P., & Halushka, P. V.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 73
- Issue
- 1
- Pages
- 122-130
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2108925673
- Cited by
- 266
- References
- 0
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic variation in cyclooxygenase 1: Effects on response to aspirin. https://app.cochat.ai/papers/10.1067/mcp.2003.1
- The paper
- Halushka, M. K., Walker, L. P., & Halushka, P. V. (2003). Genetic variation in cyclooxygenase 1: Effects on response to aspirin. Clinical Pharmacology & Therapeutics. https://doi.org/10.1067/mcp.2003.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.